bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.01.17.633359

Oral-stomach sampling to replace rumen-fistulated animals in ruminant nutrition research - a case study

Abstract

Studies using fistulated ruminants have shed light on digestion and fermentation in the rumen and yielded tools to determine the feed efficiency of diets, limit effluents or anticipate variability in the quality of animal products. However, the ethical acceptability of such studies has been called into question. Our objective was to determine whether oral-stomach sampling (OSS) is an acceptable alternative to sampling through a ruminal cannula in characterizing the variability of rumen fluid composition induced by an acidogenic dietary challenge in dairy cows. During three four-week periods (P1, P2, P3), six rumen-fistulated cows were fed a standard diet based on supplemented corn silage (periods 1 and 3) alternating with a diet enriched with starch (period 2). Rumen juice was collected through cannulas at three locations in the rumen (reticulum, ventral sac or a mix of both) and by OSS, once per week at 0830 h, i.e. before morning feeding, and once every third week of each period at 1330 h, i.e. 4.5 hours after morning feeding. Whatever the sampling method or location, ruminal pH was lower in period 2 compared to periods 1 and 3 at 1330 h (6.21 vs. 5.57 vs. 6.12 in periods 1, 2 and 3). Ruminal pH was higher when obtained by OSS rather than cannulation, whatever the sampling location (on average, +0.44 points at 0830 h and +0.56 points at 1330 h). Mineral composition indicated a presumed dilution by saliva of OSS samples. This was also consistent with lower concentrations of volatile fatty acids. The next steps will be to analyze the associated variations in in vitro rumen fermentation parameters and microbiota composition. ImplicationsThe use of fistulated ruminants to elucidate ruminal physiology is currently controversial in society. In order to minimise, reduce or replace these experimental models, alternatives to ruminal fistula sampling are being evaluated. Here we focus on oral stomach sampling (OSS). We show that OSS can be a satisfactory alternative to cannula sampling in the evaluation of rumen fermentation parameters, especially for the molar proportion of volatile fatty acids, rumen pH, and rumen volatile fatty acid and ammonia concentrations. We also show that OSS must be standardized to avoid salivary contamination affecting the quality of the results.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Boudon, A., Kwaitkowski, D., Niderkorn, V., Forano, E., Noziere, P., Silberberg, M.. 2025-01-22. Oral-stomach sampling to replace rumen-fistulated animals in ruminant nutrition research - a case study. https://doi.org/10.1101/2025.01.17.633359

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗